Related Experiment Video
Updated: Feb 16, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Optimal course of treatment in acute cardiogenic shock complicating myocardial infarction
Sebastian Nuding1, Karl Werdan1, Roland Prondzinsky2
1a Department of Medicine III , University Hospital Halle (Saale) , Halle (Saale) , Germany.
Insights
Cardiogenic shock complicating myocardial infarction has high mortality. Optimal care requires rapid intervention and intensive management, as intra-aortic balloon pumps do not improve survival.
Area of Science:
- Cardiology
- Intensive Care Medicine
Background:
- Cardiogenic shock complicates myocardial infarction in ~5% of patients, carrying a mortality rate of ≥30%.
- Prognosis is heavily influenced by organ hypoperfusion and subsequent multiple organ dysfunction syndrome.
- Early diagnosis, monitoring, and treatment are critical for patient outcomes.
Purpose of the Study:
- To review current diagnostic, monitoring, and treatment strategies for cardiogenic shock complicating myocardial infarction.
- To evaluate the effectiveness of various therapeutic approaches based on major clinical trials.
- To provide expert commentary on optimal patient care pathways.
Main Methods:
- Comprehensive literature search of major clinical trials related to cardiogenic shock in myocardial infarction.
- Review of diagnostic criteria, hemodynamic monitoring techniques, and therapeutic interventions.
- Synthesis of recent data and expert opinion on patient management.
Main Results:
- Primary percutaneous coronary intervention is the most successful therapeutic approach.
- Intensive care medicine is crucial for preventing multiple organ dysfunction syndrome and reducing mortality.
- Intra-aortic balloon pump use has not demonstrated a reduction in mortality for these patients.
Conclusions:
- Optimal management necessitates timely revascularization and advanced intensive care.
- Avoiding organ hypoperfusion is paramount for improving survival rates.
- Current evidence suggests intra-aortic balloon pumps are ineffective in reducing mortality in this setting.
Introduction:
About 5% of patients with myocardial infarction suffer from cardiogenic shock as a complication, with a mortality of ≥30%. Primary percutaneous coronary intervention as soon as possible is the most successful therapeutic approach. Prognosis depends not only on the extent of infarction, but also - and even more - on organ hypoperfusion with consequent development of multiple organ dysfunction syndrome. Areas covered: This review covers diagnostic, monitoring and treatment concepts relevant for caring patients with cardiogenic shock complicating myocardial infarction. All major clinical trials have been selected for review of the recent data. Expert commentary: For optimal care, not only primary percutaneous intervention of the occluded coronary artery is necessary, but also best intensive care medicine avoiding the development of multiple organ dysfunction syndrome and finally death. On contrary, intra-aortic balloon pump - though used for decades - is unable to reduce mortality of patients with cardiogenic shock complicating myocardial infarction.
Related Concept Videos
Shock Waves
When the source's speed approaches the speed of sound, constructive interference between successive wavefronts emitted by the source occurs immediately behind it. Initially, scientists believed that this constructive interference would result in such high...
Hemodialysis II: Procedure and Complications
Pneumonia III: Complications and Assessment
Diabetes: Symptoms, Diagnosis, and Complications
Asthma-III: Symptoms and Complications
Classification of Asthma
Optimal Foraging

